Dr Cheryl McFarlane (PhD) Tablet Image Dr Cheryl McFarlane (PhD) Mobile Image
Mobile Gradient

Dr Cheryl McFarlane (PhD)

Assay Development and Validation Manager

Almac Diagnostic Services


Current Role: 

Dr McFarlane has overall responsibility for the development and analytical validation of molecular diagnostic tests, from RUO and IUO Clinical Trial Assays through to IVD Companion Diagnostic (CDx) tests.  She has worked for over 13 years in the field of translational molecular oncology

Previous Experience:

Prior to joining Almac, Dr McFarlane obtained a PhD from Queen’s University Belfast. She subsequently completed postdoctoral fellowships where she specialized in the identification and validation of novel therapeutic targets in the Ubiquitin Proteasome system.

Joined Almac:


Dr Cheryl McFarlane (PhD)

Email Icon
Drop us a note
Linkedin Icon
Follow Almac Group

Get in touch

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies